{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:53:45Z","timestamp":1771232025772,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.drugalcdep.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T21:30:27Z","timestamp":1406583027000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Separate and combined effects of the GABAA positive allosteric modulator diazepam and \u03949-THC in humans discriminating \u03949-THC"],"prefix":"10.1016","volume":"143","author":[{"given":"Joshua A.","family":"Lile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","article-title":"Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats","volume":"118","author":"Barrett","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0015","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1002\/j.1552-4604.1981.tb02599.x","article-title":"Discriminative stimulus properties of delta 9-tetrahydrocannabinol: mechanistic studies","volume":"21","author":"Browne","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0376-8716(94)90163-5","article-title":"Relationship between subjective effects and drug preferences: ethanol and diazepam","volume":"34","author":"Chutuape","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0376-8716(86)90068-2","article-title":"Individual differences in the reinforcing and subjective effects of amphetamine and diazepam","volume":"16","author":"de Wit","year":"1986","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02246172","article-title":"Preference for diazepam but not buspirone, in moderate drinkers","volume":"123","author":"Evans","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0035","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1002\/j.1552-4604.1981.tb02618.x","article-title":"Single-dose study of nabilone in anxious volunteers","volume":"21","author":"Glass","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0040","first-page":"7","article-title":"Pharmacology of benzodiazepine hypnotics","volume":"53","author":"Greenblatt","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0045","first-page":"31","article-title":"Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds","volume":"66","author":"Griffiths","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","article-title":"Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans","volume":"4","author":"Griffiths","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-005-2234-2","article-title":"Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure","volume":"181","author":"Hart","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-3057(89)90369-9","article-title":"Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports and performance","volume":"34","author":"Heishman","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cpt1974163part1479","article-title":"Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular and oral administration","volume":"16","author":"Hillestad","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0070","doi-asserted-by":"crossref","first-page":"171S","DOI":"10.1002\/j.1552-4604.1981.tb02593.x","article-title":"Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?","volume":"21","author":"Hollister","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00174684","article-title":"Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils","volume":"94","author":"J\u00e4rbe","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00008877-199402000-00008","article-title":"The effects of delta 9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-reports in humans","volume":"5","author":"Kamien","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FBP.0b013e3283305e8d","article-title":"Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers","volume":"20","author":"Kelly","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jat\/17.5.264","article-title":"Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol and diazepam","volume":"17","author":"Kelly","year":"1993","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0278-5846(90)90075-R","article-title":"Multidimensional behavioral effects of marijuana","volume":"14","author":"Kelly","year":"1990","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcph.90","article-title":"Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of \u0394(9)-THC in cannabis users","volume":"53","author":"Lile","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2010.11.019","article-title":"Separate and combined effects of the cannabinoid agonists nabilone and \u03949-THC in humans discriminating \u0394(9)-THC","volume":"116","author":"Lile","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2011.09.010","article-title":"Separate and combined effects of the GABA reuptake inhibitor tiagabine and \u03949-THC in humans discriminating \u0394(9)-THC","volume":"122","author":"Lile","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.drugalcdep.2012.05.023","article-title":"Separate and combined effects of the GABAB agonist baclofen and \u03949-THC in humans discriminating \u0394(9)-THC","volume":"126","author":"Lile","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-008-1393-3","article-title":"Substitution profile of \u03949-tetrahydrocannabinol, triazolam, hydromorphone and methylphenidate in humans discriminating \u03949-tetrahydrocannabinol","volume":"203","author":"Lile","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0130","unstructured":"Marinol\u00ae Product Information, 2006. Solvay Pharmaceuticals Inc."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the Digit Symbol Substitution Test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav. Res. Methods Instrum."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0140","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0024-3205(86)90497-2","article-title":"The role of benzodiazepine receptors in the discriminative stimulus properties of delta 9-tetrahydrocannabinol","volume":"38","author":"Mokler","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-198325040-00003","article-title":"Benzodiazepine dependence. A review of the evidence","volume":"25","author":"Owen","year":"1983","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","article-title":"Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion and triazolam in d-amphetamine trained humans","volume":"6","author":"Rush","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0165","series-title":"The Effects of Drugs on Human Performance and Behavior: Drugs and Driving\/Drugs in the Workplace","article-title":"DRE field testing of drug impaired drivers","author":"Toland","year":"1991"},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0170","unstructured":"Valium\u00ae Product Information, 2013. Genentech, Inc."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","article-title":"Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal","volume":"117","author":"Vandrey","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0091-3057(99)00130-6","article-title":"Effects of SR141716A on diazepam substitution for delta 9-tetrahydrocannabinol in rat drug discrimination","volume":"64","author":"Wiley","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(03)01856-9","article-title":"Cannabinoid pharmacological properties common to other centrally acting drugs","volume":"471","author":"Wiley","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(94)90031-0","article-title":"Effects of marijuana on performance of a computerized cognitive-neuromotor test battery","volume":"51","author":"Wilson","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2014.07.016_bib0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:20:29Z","timestamp":1538371229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614009880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":38,"alternative-id":["S0376871614009880"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separate and combined effects of the GABAA positive allosteric modulator diazepam and \u03949-THC in humans discriminating \u03949-THC","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}